A new non-hormonal drug has been approved to treat menopausal hot flushes. It works by regulating the body's cooling signals and is now available on the NHS in England for those who cannot use hormone replacement therapy.

Before delving into the evidence with resident GP Dr Margaret McCartney, James finds out what it feels like to have a hot flush.

Also this week, James chats to Dr Manjula Meda, a microbiologist who is spearheading a radical new project. She has found that water systems in hospitals may be a breeding ground for antimicrobial resistance, and is tackling this by removing the sinks from wards. Is it effective and safe?

Finally, we all do it, but we don't like discussing it... Farting. James speaks to the University of Maryland's Professor Brantley Hall, who has developed a 'fart detector' that can measure emissions to get a better understanding of gut health. And James gets the chance to attach one to his pants for three days. For science, of course.

Presenter: James Gallagher

Little over a week on from the first meningitis cases in Canterbury, many crucial questions remain.

So this week we're taking an in-depth look at those questions and what we’ve learnt from this outbreak - and could it happen again?

James also hears from author Michael Rosen whose son Eddie died from meningitis aged 18 about just how quickly the disease struck and how he deals with his grief.

And would you trust health advice from an AI chatbot?

We hear from someone who regularly turns to ChatGPT and from GP Dr Margaret McCartney about her concerns.

Presenter: James Gallagher

Inside Health was made by the BBC’s Audio Science Unit in collaboration with The Open University.

More than 30,000 people are being contacted in the Canterbury area regarding the outbreak of bacterial meningitis in Kent. Two people have died, and others are seriously ill. James Gallagher speaks with immunologist Sir Andrew Pollard about the disease, and finds out what could have caused the outbreak.

That’s the major headline from the UK. But more broadly, for the last few weeks the news has been dominated by the situation in the Middle East. James speaks with Dr Antoine Abou Fayad, a microbiologist and medicinal chemist based in Beirut, Lebanon. He reveals that war, just like the ongoing conflict in the Middle East, provides the perfect storm to accelerate the spread of multidrug-resistant infections. And nobody is safe.

Presenter: James Gallagher

There have been nearly 200 cases of measles in the UK so far this year.

Measles can be prevented with vaccines - but the proportion of children being immunised is declining across the UK, particularly in parts of London.

James visits Hackney, which has one of the lowest vaccination rates in the country, to find out why and to see what is happening to tackle this issue.

And have you tried an adaptogenic drink? They claim to relax the mind, without giving you a boozy hangover.

James samples some in the lab and then gets behind the wheel of a simulator to see what it does to his driving skills…

Presenter: James Gallagher

Inside Health was made by the BBC’s Audio Science Unit in collaboration with The Open University.

Penis fillers were an unexpected talking point at the recent Winter Olympics after claims that male ski jumpers were having them to improve performance.

So this week we’re digging into the UK’s penis filler industry.

James visits a private clinic in Manchester to hear about about the procedure, which involves hyaluronic acid being injected to temporarily increase penis girth. 

He meets Jason, who had his first penis filler five months’ ago, and he explains why he wanted it and how he weighed up the risks versus the benefits.

James also chats to an NHS surgeon who says increasing numbers of men are seeking out the procedure - and he is dealing with the consequences when it goes wrong.

Also this week, why is aspirin in short supply?

Presenter: James Gallagher

The show was made by the BBC’s Audio Science Unit in collaboration with The Open University.

ME – also known as Chronic Fatigue Syndrome – has long been one of medicine’s most perplexing conditions. With no definitive diagnostic test and a legacy of scepticism in parts of the medical community, patients have often struggled to be believed. But a surge of new research may finally be shifting the landscape.

In this episode, James Gallagher speaks to Dr Chris Ponting about the latest DecodeME results, which point to a strong genetic component to ME. And Professor Rosemary Boyton outlines the ambition behind the new Rosetta Stone study, designed to build a detailed evidence base of shared biomarkers across ME and Long COVID.

Presenter: James Gallagher

Over 1.5million adults in the UK tried weight loss drugs in 2024-25. Many swear by them, but they have been associated with side effects including nausea and, in some cases, extremely painful gallstones. But what does the evidence actually tell us, and what is the wider impact on the way we view our bodies in society?

James Gallagher is joined by Professor of Cardiometabolic Medicine at the University of Glasgow Naveed Sattar, Dr Beverley O’Hara, Lecturer in Public Health Nutrition at Leeds Beckett University, and Dr Margaret McCartney, resident Inside Health GP. They discuss what the evidence tells us about the potential known side effects of these weight loss drugs, and the potential impact their use has on our view of obesity as a society. We also hear from Sarah Le Brocq, who has struggled with obesity all her adult life and has been on these drugs for the past 2-3 years about her experiences.

Margaret McCartney has no conflicts of interest to declare.

Beverley O’Hara has no conflicts of interest to declare. She has 2 roles with the Association for the Study of Obesity (voluntary academic positions).

Naveed Sattar has consulted for and/or received speaker honoraria from AbbVie, Amgen, AstraZeneca, Boehringer Ingelheim, Carmot Therapeutics, Eli Lilly, Gan & Lee, GlaxoSmithKline, Hanmi Pharmaceuticals, Kailera, Mass Medicines, Menarini-Ricerche, Metsera, Novo Nordisk, Pfizer, Regeneron, Roche, UCB Pharma, and Verdiva Bio; and received grant support paid to his University from AstraZeneca, Boehringer Ingelheim, Novartis, and Roche.

Presenter: James Gallagher

Dentistry is high on the public and political agenda. There have been dozens of headlines about access to NHS dentistry, with some people having to travel huge distances to find a dentist, or being put onto long waiting lists to get an NHS appointment.

In this episode of Inside Health, James Gallagher is joined by chairman of the British Dental Association Eddie Crouch, the Oral Health Foundation's Dr Rachael England, and consultant oral surgeon Tom Thayer. Together, they drill into the issues surrounding NHS dentistry. Along the way, they discuss possible solutions, whether contract reforms will help, and the potential future of dentistry in the UK.

Presenter: James Gallagher

Most of us have Epstein-Barr Virus (EBV) hiding in our bodies.

You may know it as the cause of glandular fever or “kissing disease”.

But more research is suggesting that it can turn our immune systems against us to cause autoimmune disease, such as multiple sclerosis or lupus.

James is joined by Dr Claire Shannon-Lowe, a virologist at the University of Birmingham, and Dr Patrick Kearns from the University of Edinburgh, a neurologist and epidemiologist.

And we delve into the world of echolocation.

Bats hunt at night by making pulses of sounds and listening to the echoes so they can build a picture of the world around them in total darkness - and it's a technique some people with visual impairment use to explore the world.

A team at the University of East Anglia has been testing how well humans can pick up these skills, so James pays a visit to have a go...

Presenter: James Gallagher

This week we’re looking at government plans to start sequencing the DNA of every newborn baby in England within the next decade.

Each newborn would undergo whole genome sequencing to assess their risk of hundreds of diseases, under NHS plans.

It promises a revolution in spotting disease early - but are there also risks?

And use of nicotine pouches is rising, especially among young men.

But these little sachets that fit under the top lip aren’t yet regulated – so what do we know about the potential harms?

Finally, as the cold weather continues, James gets a lesson in walking like a penguin to see if it helps avoid trips, slips and falls…